Anavex: Looking Very Promising

Personal circumstances sparked my curiosity about Alzheimer’s Disease (AD). By extension, I started doing research on biotechnology companies focusing on AD drugs.

Late 2017, a biotech active in R&D for AD caught my eye: Anavex Life Sciences ($AVXL).

Anavex was entering stage II/III clinical trials.

Avanex´s stock price has a 52 week high/low of US$5.63/$2.18 with good liquidity of 700k daily on average. With the shares trading at the very low-end of the range, it looks like a great time to build a position. 

What you should know about AD:

Alzheimer’s is a type of dementia that causes memory, thinking and behavioral problems. AD will affect 1 in 3 people directly. Symptoms usually develop slowly and worsen over time, becoming severe enough to interfere with daily tasks. It’s an absolutely devastating disease.

To date, AD has no cure.

Blue sand falls in an hourglass on a rocky beach

Why I like Anavex LS:

There are three reasons why I have high hopes for $AVXL

  • First, their very impressive team of renowned doctors and scientists, led by Dr. Missling (MS, MBA and PhD in Chemistry). As we’re taught in 101 lessons on investing: “It’s not just about the idea, but the execution of it”. 
  • Second, Anavex deploys cutting-edge technology and precision genetic medicine focusing on neurological diseases with no available therapies. Their reports, targets and research models are well-thought-out, which aligns with the fact that they have reached phase II/III clinical trials.
  • Third, with the stock trading at US$ 2.17, a market cap of only US$ 97M, and a short interest of 17% of the outstanding, with some positive results, the shares should explode upward. US$8.00 in the near term seems achievable.

Fundamentals and technicals point to a bullish picture for $AVXL over the coming year. (Nothing would make me happier than a drug to treat my beloved Grandma coming to market 😊).

The risk/reward for buying $AVXL is very promising… Get long!

Happy investing!

Dr. Anna Morera Leralta 

 

Anna Morera Leralta

Medical Doctor specializing in Integrative Medicine and exploring the Medical Cannabis opportunity. Also fascinated by the convergence of Life Sciences and Technology - in particular Artificial Intelligence and how it will affect health care in the future. During my internships and volunteering, I have worked hand-in-hand with well-know physicians and professionals of the Health-Biotech sector. I've been awarded with numerous awards of excellence and scholastic scholarships. I'm a co-founder of an IoT startup that aims to help smokers successfully quit. Born and raised in Barcelona - Spain, with a zest for traveling, learning and expanding my horizons. Always curious, hard-working, open-minded and self-motivated.

No Comments Yet

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe to the IBR blog

Keep up to date with our latest news and recommendations by getting them straight to your inbox!

We will never spam you or give your email address to a third party.